Arcus Biosciences Inc Shares Close the Day 10.1% Lower - Daily Wrap
The company saw its shares close the day 10.1% lower than yesterday, with trading volume higher than its 30 day average.
May 18, 2022 by Kwhen Finance Editors
Arcus Biosciences Inc (RCUS) shares closed today 10.1% lower than it did at the end of yesterday. The stock is currently down 48.1% year-to-date, down 25.0% over the past 12 months, and up 23.5% over the past five years. Today, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 2.1%.
Trading Activity
- Shares traded as high as $21.37 and as low as $16.74 this week.
- Shares closed 61.6% below its 52-week high and 12.7% above its 52-week low.
- Trading volume this week was 66.7% lower than the 10-day average and 37.4% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Arcus Biosciences Inc | -10.1 | -48.1 | -25.0 | -59.0 | 20.3 |
| Dow Jones Industrial Average | 1.3 | -9.5 | -3.2 | -11.1 | 4.6 |
| S&P 500 Index | 2.1 | -13.8 | -0.4 | -15.0 | 5.5 |
| Health Care | -0.8 | -8.4 | 4.9 | -9.7 | 5.9 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 79.7%
- The company's stock price performance over the past 12 months beats the peer average by -12.2%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Arcus Biosciences Inc | RCUS | 0 | -48.1 | -25.0 | -59.0 | 20.3 |
| Peer Avg | N/A | 0 | -26.8 | -28.4 | ||
| Ovid Therapeutics Inc | OVID | 0 | -32.7 | -41.1 | ||
| Oyster Point Pharma Inc | OYST | 0 | -74.4 | -72.5 | ||
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: